Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / May / Tracking TB with Rare Sugar Signature
Infectious Disease Analytical science Microscopy and imaging

Tracking TB with Rare Sugar Signature

Site-specific labelling of tuberculosis pathogen opens avenues in disease diagnostics

05/13/2025 News 2 min read

Share

Researchers have developed a method to label specific sugars, or glycans, on the surface of Mycobacterium tuberculosis (Mtb) by targeting a rare chemical feature. This approach offers a potential new avenue for tracking and understanding key bacterial components involved in the world's deadliest pathogen – and future diseases.

The study, published in PNAS, focuses on methylthioxylofuranose (MTX), a rare sugar which is found in certain mycobacterial pathogens. MTX is part of mannose-capped lipoarabinomannan (ManLAM), a molecule on the surface of Mtb that affects how the immune system responds to infection. A thioether group – a chemical feature that is unusual in sugars – on MTX enables selective labeling using oxaziridine-based reagents.

The team demonstrated that oxaziridine probes can react with the MTX thioether in vitro and in living cells, enabling site-selective labeling of MTX-containing glycans. The labeling was specific to Mtb and did not occur in non-harmful mycobacteria. Using this technique, they were able to see where ManLAM was located in bacteria and in infected immune cells, using fluorescence microscopy.

The labeling approach proved specific despite the presence of other sulfur-containing molecules, such as methionine in proteins. This chemical precision is critical for downstream diagnostic applications, where nonspecific signals can lead to false results.

This study also highlights this method's potential to support the development of new diagnostic tools that detect Mtb directly in samples like tissue or sputum. Unlike tests that rely on detecting immune responses or bacterial DNA, this approach could provide more direct and localized information about where bacteria are active during infection.

While this study focused on proof-of-concept labeling and visualization, the authors note that it could be adapted for use in clinical samples and potentially expanded to other bacterial studies. The unique chemical reactivity of MTX could also be applied to broader applications, such as designing new diagnostic or research tools related to glycan biology and infectious disease.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Viral Frontier
Infectious Disease
The Viral Frontier

January 23, 2024

1 min read

The latest on the UK COVID-19 inquiry

What’s New in Infectious Disease? (December 2021)
Infectious Disease
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Infectious Disease
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

Pneumocystis Mysteries
Infectious Disease
Pneumocystis Mysteries

January 21, 2022

1 min read

What is the correct name for this pneumonia-causing pathogen?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.